Biofrontera (BFRIW) Stock: Why It's Down Today
Updated Oct 20, 2026, 1:16 PM ET · intraday price
- Trading at $0.01 as of 1:16 PM ET, -14.75% vs the prior close of $0.01.
- Volume 13.49K shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)
BFRIW slides 14.8% to $0.01. Trading at $0.01 (intraday, 1:16 PM ET), -14.75% vs the prior close of $0.01. Day range $0.01–$0.01, opened at $0.10.
BFRIW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — BFRIW slides 14.8% to $0.01
- Trading at $0.01 (intraday, 1:16 PM ET), -14.75% vs the prior close of $0.01. Day range $0.01–$0.01, opened at $0.10.
- Volume was 13.49K shares, 1.1x its 50-day average of 11.98K.
- 52-week range $0.01–$0.01; the current price sits at 10% of that range, 14.8% below the 52-week high.
Oct 19, 2026 — BFRIW ends flat (+0.0%) to $0.01 on 163.7x normal volume
- Closed at $0.01, +0.00% vs the prior close of $0.01. Day range $0.01–$0.01, opened at $0.10.
- Volume was 982 shares, 163.7x its 50-day average of 6 — unusually heavy trading.
- 52-week range $0.01–$0.01; today's close sits at 0% of that range, 14.8% below the 52-week high.
BFRIW bull case vs bear case (from the data)
- Annual revenue grew 11.7% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: loss of $10.54M.
- Share count up 39.2% in a year (dilution).
- High volatility: average daily move of 14.8% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
BFRIW latest news & SEC filings
Every SEC filing by or about BFRIW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $12.00M (prior year $9.03M) (+32.9% vs Jun 30, 2025)
- Net income: -$604.00K (prior year -$5.32M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.05 (prior year -$0.57) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 22, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 22, 2026 · Form 10-K/A — Annual report (amended)
Amended annual report
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Things to know before you trade BFRIW
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 19, 2026, Jan 13, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 14.75% (largest 14.8%). That is a volatile stock.
- Liquidity: about 12.73K shares (≈$66) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.01 vs a range of $0.01–$0.01 (10% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 14, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 14.85M shares outstanding (Aug 11, 2026), +39.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BFRIW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 0.10 | 0.01 | 0.01 | 0.01 | 13.49K |
| Oct 19, 2026 | 0.10 | 0.01 | 0.01 | 0.01 | 11.98K |
About Biofrontera
Biofrontera (BFRIW) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WOBURN, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1858685.
BFRIW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John J Iii Borer | Director | Mar 6, 2026 |
| Beth J. Hoffman | Director | Mar 6, 2026 |
| Heikki Lanckriet | Director | Mar 6, 2026 |
| Hermann Luebbert | CEO & Chairman | Jul 29, 2026 |
| Kevin Daniel Weber | Director | Mar 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| George Patrick Jones | Chief Commercial Officer | Mar 6, 2026 |
| Eugene Frederick Leffler | Chief Financial Officer | Jul 29, 2026 |
| Hermann Luebbert | CEO & Chairman | Jul 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BFRIW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $41.70M | $-10.54M | -1.04 | $-13.36M |
| Dec 31, 2024 | $37.32M | $-17.76M | -3.22 | $-10.27M |
| Dec 31, 2023 | $34.07M | $-20.13M | -13.02 | $-24.89M |
| Dec 31, 2022 | $28.67M | $-640.00K | -0.61 | $-16.20M |
| Dec 31, 2021 | $24.10M | $-37.71M | — | $-26.71M |
Latest balance sheet: total assets $24.06M, total liabilities $18.11M, cash $4.66M (as of Jun 30, 2026).
BFRIW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | — |
| May 14, 2026 | 8-K Item 2.02 (results) | — |
| Mar 19, 2026 | 8-K Item 2.02 (results) | — |
| Jan 13, 2026 | 8-K Item 2.02 (results) | — |
| Nov 13, 2025 | 8-K Item 2.02 (results) | — |
| Aug 13, 2025 | 8-K Item 2.02 (results) | — |
| May 15, 2025 | 8-K Item 2.02 (results) | — |
| Mar 21, 2025 | 8-K Item 2.02 (results) | — |
| Nov 13, 2024 | 8-K Item 2.02 (results) | — |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 15, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)United Therapeutics (UTHR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on BFRIW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 1:16 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.